{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T04:33:57Z","timestamp":1774758837211,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.eimc.2020.01.018","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T01:31:47Z","timestamp":1583890307000},"page":"489-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Therapy of Staphylococcus aureus bacteremia: Evidences and challenges"],"prefix":"10.1016","volume":"38","author":[{"given":"Luis Eduardo","family":"L\u00f3pez-Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"G\u00e1lvez-Acebal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2020.01.018_bib0315","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1469-0691.2012.03903.x","article-title":"The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study","volume":"19","author":"Laupland","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2020.01.018_bib0320","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jinf.2018.08.015","article-title":"Survival following Staphylococcus aureus bloodstream infection: a prospective multinational cohort study assessing the impact of place of care","volume":"77","author":"Nambiar","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2020.01.018_bib0325","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.mayocp.2017.07.008","article-title":"Statin use and risk of community-acquired Staphylococcus aureus bacteremia: a population-based case\u2013control study","volume":"92","author":"Smit","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eimc.2020.01.018_bib0330","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cmi.2018.07.015","article-title":"Time to blood culture positivity: an independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia","volume":"25","author":"Sim\u00e9on","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2020.01.018_bib0335","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis","volume":"312","author":"Kalil","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2020.01.018_bib0340","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"54","author":"Van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0345","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3201\/eid1706.101037","article-title":"High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia","volume":"17","author":"Aguado","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0350","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0355","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1093\/jac\/dkv133","article-title":"Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?","volume":"70","author":"L\u00f3pez-Cort\u00e9s","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2020.01.018_bib0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(12)70238-4","article-title":"The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis","volume":"13","author":"Shallcross","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0365","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10096-016-2603-2","article-title":"Relationship between pathogenic, clinical, and virulence factors of Staphylococcus aureus in infective endocarditis versus uncomplicated bacteremia: a case-control study","volume":"35","author":"Gallardo-Garc\u00eda","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0370","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/cid\/ciy739","article-title":"A Prognostic model of persistent bacteremia and mortality in complicated Staphylococcus aureus bloodstream infection","volume":"68","author":"Guimaraes","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"5.","key":"10.1016\/j.eimc.2020.01.018_bib0375","article-title":"Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"63","author":"Geriak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2020.01.018_bib0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archinte.162.1.25","article-title":"Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases","volume":"162","author":"Jensen","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2020.01.018_bib0385","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0953-6205(03)00063-3","article-title":"Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis","volume":"14","author":"Lesens","year":"2003","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.eimc.2020.01.018_bib0390","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10096-016-2598-8","article-title":"Risk factors for long-term mortality of Staphylococcus aureus bacteremia","volume":"35","author":"Yahav","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0395","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmi.2016.06.002","article-title":"Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study","volume":"23","author":"Smit","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2020.01.018_bib0400","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/514686","article-title":"Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients","volume":"27","author":"Fowler","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0405","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s15010-018-1130-8","article-title":"Essentials in the management of S. aureus bloodstream infection","volume":"46","author":"Jung","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.eimc.2020.01.018_bib0410","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/civ235","article-title":"Predicting risk of endocarditis using a clinical tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia","volume":"61","author":"Palraj","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0415","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2016.02.003","article-title":"The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia","volume":"72","author":"Tubiana","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2020.01.018_bib0420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2015.09.037","article-title":"Infectious disease consultation for Staphylococcus aureus bacteremia \u2013 a systematic review and meta-analysis","volume":"72","author":"Vogel","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.eimc.2020.01.018_bib0425","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1144","article-title":"Clinical practice variation among adult infectious diseases physicians in the management of Staphylococcus aureus bacteremia","author":"Liu","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0430","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/cit499","article-title":"Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia","volume":"57","author":"L\u00f3pez-Cort\u00e9s","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0435","first-page":"3390","article-title":"Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study","volume":"70","author":"Nguyen","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2020.01.018_bib0440","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s15010-016-0946-3","article-title":"Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis","volume":"45","author":"Nagao","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.eimc.2020.01.018_bib0445","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/jac\/dkw582","article-title":"Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT)","volume":"72","author":"Voumard","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2020.01.018_bib0450","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijantimicag.2018.11.013","article-title":"Cefazolin vs. anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections in acutely ill adult patients: results of a systematic review and meta-analysis","volume":"53","author":"Lee","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2020.01.018_bib0455","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12879-018-3418-9","article-title":"Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis","volume":"18","author":"Shi","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0460","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy123","article-title":"The cefazolin inoculum effect is associated with increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"5","author":"Miller","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0465","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/AAC.00052-12","article-title":"Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus","volume":"56","author":"Livorsi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2020.01.018_bib0470","unstructured":"Non-inferiority trial comparing cloxacillin vs cefazolin in methicillin-susceptible Staphylococcus aureus bacteremia (CLOCEBA). Available from: www.clinicaltrials.gov\/ [accessed 02.10.19]."},{"key":"10.1016\/j.eimc.2020.01.018_bib0475","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1213\/ANE.0000000000003419","article-title":"Misconceptions surrounding penicillin allergy: implications for anesthesiologists","volume":"127","author":"Vorobeichik","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.eimc.2020.01.018_bib0480","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1128\/AAC.02504-13","article-title":"Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting","volume":"58","author":"Blumenthal","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2020.01.018_bib0485","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1086\/595686","article-title":"Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study","volume":"48","author":"Wilcox","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0490","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/dki355","article-title":"Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies","volume":"56","author":"Shorr","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2020.01.018_bib0495","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2020.01.018_bib0500","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/cid\/ciu165","article-title":"The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function","volume":"58","author":"Weston","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0505","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/cid\/cit112","article-title":"Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1mg\/L: a matched cohort study","volume":"56","author":"Murray","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0510","doi-asserted-by":"crossref","first-page":"h2219","DOI":"10.1136\/bmj.h2219","article-title":"Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial","volume":"350","author":"Paul","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.eimc.2020.01.018_bib0515","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12941-019-0329-6","article-title":"DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and\/or bloodstream infection produced by gram-positive cocci","volume":"18","author":"Hidalgo-Tenorio","year":"2019","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.eimc.2020.01.018_bib0520","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ijantimicag.2014.07.024","article-title":"Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations","volume":"44","author":"Paladino","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2020.01.018_bib0525","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/IPC.0000000000000191","article-title":"Ceftaroline fosamil for the treatment of Staphylococcus aureus bacteremia secondary to acute bacterial skin and skin structure Infections or community-acquired bacterial pneumonia","volume":"23","author":"Vazquez","year":"2015","journal-title":"Infect Dis Clin Pract (Baltim Md)"},{"key":"10.1016\/j.eimc.2020.01.018_bib0530","article-title":"A pooled analysis of clinical cure and mortality with ceftobiprole medocaril versus comparators in staphylococcal bacteraemia in complicated skin infections, and community- and hospital-acquired pneumonia","author":"Rello","year":"2016","journal-title":"ECCMID"},{"key":"10.1016\/j.eimc.2020.01.018_bib0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.eimc.2015.03.014","article-title":"Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)","volume":"33","author":"Gudiol","year":"2015","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"10121","key":"10.1016\/j.eimc.2020.01.018_bib0540","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2020.01.018_bib0545","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s10096-016-2893-4","article-title":"Empirical combination of a \u03b2-lactam to vancomycin may not improve outcomes of methicillin susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy","volume":"36","author":"Park","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0550","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/AAC.02192-12","article-title":"Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant beta-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment","volume":"57","author":"Moise","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2020.01.018_bib0555","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/cid\/ciz018","article-title":"Impact of \u03b2-lactam and daptomycin combination therapy on clinical outcomes in methicillin-susceptible Staphylococcus aureus bacteremia: a propensity score-matched analysis","volume":"69","author":"Grillo","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0560","unstructured":"Efficacy of cloxacillin and fosfomycin combination versus cloxacillin monotherapy in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: the SAFO Trial. Available from: www.clinicaltrials.gov\/ [accessed 02.10.19]."},{"key":"10.1016\/j.eimc.2020.01.018_bib0565","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eimc.2018.05.009","article-title":"Clinical efficacy of fosfomycin combinations against a variety of gram-positive cocci","volume":"37","author":"Coronado-\u00c1lvarez","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"3.","key":"10.1016\/j.eimc.2020.01.018_bib0570","article-title":"Adjuvant \u03b2-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus bacteremia: does \u03b2-lactam class matter?","volume":"63","author":"Dilworth","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2020.01.018_bib0575","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/phar.2034","article-title":"Early administration of adjuvant \u03b2-lactam therapy in combination with vancomycin among patients with methicillin-resistant Staphylococcus aureus bloodstream infection: a retrospective, multicenter analysis","volume":"37","author":"Casapao","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eimc.2020.01.018_bib0580","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of vancomycin and \u03b2-Lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial","volume":"62","author":"Davis","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0585","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13063-016-1295-3","article-title":"CAMERA2 \u2013 combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial","volume":"17","author":"Tong","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.eimc.2020.01.018_bib0590","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/CCM.0000000000002769","article-title":"Vancomycin plus piperacillin-tazobactam and acute kidney injury in adults: a systematic review and meta-analysis","volume":"46","author":"Luther","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2020.01.018_bib0595","article-title":"Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study","author":"Jorgensen","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0600","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/cid\/ciu580","article-title":"Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial","volume":"59","author":"del R\u00edo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2020.01.018_bib0605","article-title":"Daptomycin plus fosfomycin versus daptomycin monotherapy for methicillin-resistant Staphylococcus aureus bacteremia. A multicenter, randomized, clinical trial","author":"Pujol","year":"2018","journal-title":"IDWeek"},{"key":"10.1016\/j.eimc.2020.01.018_bib0610","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","article-title":"Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy","volume":"101","author":"Heldman","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2020.01.018_bib0615","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13063-015-0973-x","article-title":"Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial","volume":"16","author":"Kaasch","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.eimc.2020.01.018_bib0620","article-title":"Early oral switch to linezolid for low-risk patients with Staphylococcus aureus bloodstream infections: a propensity-matched cohort study","author":"Willekens","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X20300252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X20300252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:06:39Z","timestamp":1759323999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X20300252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0213005X20300252"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2020.01.018","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy of Staphylococcus aureus bacteremia: Evidences and challenges","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2020.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}